Navigation Links
New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
Date:10/25/2008

nzymes (ALT and AST) were seen in patients; these increases were generally mild and reversible, with no evidence of hepatic injuries. Laboratory changes, including increases in lipids (total cholesterol, LDL, HDL, triglycerides) and decreases in neutrophils and platelets, were seen in patients without association with clinical outcomes. Treatments that suppress the immune system, such as ACTEMRA, may cause an increase in the risk of malignancies.

About IL-6

IL-6 is a common protein found in all joints in the body and is a natural substance that can raise inflammation. Everyone has IL-6 in their body, but people with RA may have too much.

When approved, ACTEMRA will be the first and only medication to specifically target IL-6 in patients with RA.

About Rheumatoid Arthritis

Rheumatoid arthritis is a progressive, systemic autoimmune disease characterized by inflammation of the membrane lining in the joints. This inflammation causes a loss of joint shape and function, resulting in pain, stiffness and swelling, ultimately leading to irreversible joint destruction and disability. Characteristics of RA include redness, swelling, pain and movement limitation around joints of the hands, feet, elbows, knees and neck that leads to loss of function. In addition, the systemic symptoms of RA include fatigue, decreased hemoglobin, osteoporosis and may contribute to shortening life expectancy by affecting major organ systems. After 10 years, less than 50 percent of patients can continue to work or function normally on a daily basis. RA affects more than 21 million people worldwide with approximately 1.3 million adults affected in the United States.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche
'/>"/>

SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
3. Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
4. Mindset Media Study Reveals Which Independent Voters Favor Obama Vs. McCain
5. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
6. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
8. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
9. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
10. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
11. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore ... dei disturbi respiratori del sonno (SDB) e altre patologie ... Germania contro il produttore Taiwanese di dispositivi medicali, APEX ... da indossare in testa, che violano i brevetti, utilizzate ... sentenza della Corte Regionale Distrettuale di Monaco ...
(Date:7/28/2014)... 2014 Concord Medical Services Holdings Limited ("Concord ... a leading specialty hospital management solution provider and operator ... centers in China , today announced ... declared a special cash dividend of US$0.30 per ordinary ... the Company,s outstanding ordinary shares. The total expense for ...
(Date:7/28/2014)...  ResMed (NYSE: RMD ), an innovator ... sleep-disordered breathing and other chronic respiratory conditions, has won ... against Taiwanese medical device manufacturer APEX Medical Corp. (APEX), ... 210 and 220 masks.  The judgment was entered by ... , is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2Concord Medical Declares Special Dividend 2ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... Ill., July 28, 2011 The National ... health alert to warn Americans about the serious dangers ... report NABP released today on Internet drug outlets found ... to operate out of compliance with United States pharmacy ...
... Fla., July 28, 2011 China Nuvo Solar Energy, ... Inc. has executed a stocking distribution agreement with OptiMedical Corp. ... orthopedic, spine and ENT products selling into hospitals and surgery ... stated, "We are excited and look forward to a long ...
Cached Medicine Technology:NABP Issues Rogue Online Pharmacy Public Health Alert 2NABP Issues Rogue Online Pharmacy Public Health Alert 3NABP Issues Rogue Online Pharmacy Public Health Alert 4China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp. 2China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp. 3
(Date:7/28/2014)... (PRWEB) July 28, 2014 For those with ... prime cause of dust allergies—commonly settle in mattresses, bedding, and ... asthma. , Dust mites are microscopic insects that feed on ... skin each day to keep a million dust mites fat ... a high power microscope, the decaying bodies and feces of ...
(Date:7/28/2014)... 2014 Glidewell Laboratories announced today that ... successfully passed the five-year mark in clinical usage, and ... units prescribed by US dentists. , Even as BruxZir ... good results from respected clinical studies, many dentists expressed ... over extended years of clinical service before they would ...
(Date:7/28/2014)... July 28, 2014 "We experienced difficulty ... said one of two inventors from Jamestown, Calif. "We ... open so that we could pour medications in more ... STAY OPEN to keep the lids open as the ... closing until all compartments have been filled. This eliminates ...
(Date:7/28/2014)... This is a professional and in-depth market ... report firstly reviews the basic information of Tadalafil ... report then explores global and China’s top manufacturers ... value, and market share etc. , The report ... market of Tadalafil by calculation of main economic ...
(Date:7/28/2014)... Mahendra Trivedi, accompanied by Trivedi Masters™ ... Workshop ‘Consciousness is Power’ on July 26, 2014 from ... participants from all over the world received profound knowledge ... connection to their inner guidance system. , On this ... advantages of raising consciousness and thus, enjoying the abundance ...
Breaking Medicine News(10 mins):Health News:AllergyEasy® Announces No-shots Immunotherapy to Mitigate Dust Allergies 2Health News:AllergyEasy® Announces No-shots Immunotherapy to Mitigate Dust Allergies 3Health News:BruxZir® Solid Zirconia Surpasses Five Years of Clinical Use 2Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 4Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 2Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 3
... ... and networking resources , ... CO (Vocus) August 5, 2009 -- MedHunters is making it easier for qualified ... redesigned to include:, , ,   Niche Web ...
... ... ... -- In 1999 Christina Timmons parlayed a background in health care marketing and public relations ... , a physician job search website that will celebrate its 10th anniversary in ...
... , , Unprecedented Collaboration ... SILVER SPRING, Md., Aug. 5 For the first ... Medicine Physician Certification (OMPC) Examination. The 18-month process of establishing an ... expected completion in March 2010. According to Dr. Robert Kushner, Chair ...
... ... never develop symptoms, a phenomenon that has puzzled scientists since the first genetic mutation was ... have figured out why these mutation carriers are protected from symptoms of the disorder - ... ...
... , ALISO VIEJO, Calif., Aug. 4 ... premier anatomic pathology and molecular testing services resource for pathologists, oncologists and ... six months ended June 30, 2009. Financial results included a 40 ... second quarter of 2008, and a 43 percent increase in revenue for ...
... , Who: Jordan Thomas, 2009 National Courage Award recipient, ... traumatic injury, Events: Adapted ... Monday, Aug. 10, 2009, 8:30 a.m. to noon, ... Medtronic Celebration of Courage Gala, ...
Cached Medicine News:Health News:MedHunters Launches Redesigned Web Platform 2Health News:Ten Years Later: O.I.S. Media Leads Physician Job Board Industry with Innovative Technology 2Health News:Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 2Health News:Abnormal Brain Circuits May Prevent Movement Disorder 2Health News:Abnormal Brain Circuits May Prevent Movement Disorder 3Health News:Abnormal Brain Circuits May Prevent Movement Disorder 4Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 2Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 3Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 4Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 5Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 6Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 7Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 8Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 9Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 10Health News:National Courage Award Winner Jordan Thomas to Participate in PGA Adapted Youth Golf Clinic 2
Includes conservation device, standard cannula, batteries and instruction booklet....
Oxygen Conservation Device. Bypass 6203: Turn knob....
... The Forceps are designed to ... locking mechanism which is useful for ... When the blades are closed, the ... Pincher and Adjuster are designed to ...
... Rhein Medical announces its new CVD ... allow the incredible sharpness of diamonds to ... Proven diamond blade sharpness improves stromal reapproximation, ... result. The knives offer unlimited uses, and ...
Medicine Products: